New Method Improves Analysis of Long-Term Treatment Effects
Researchers studied how to analyze data from trials that look at the effects of treatments over time, specifically focusing on a method called Latent Change Models (LCMs).
Pediatric epilepsy research translated for parents into normal language, including summaries about diagnosis, treatments, school, safety, and safety.
Researchers studied how to analyze data from trials that look at the effects of treatments over time, specifically focusing on a method called Latent Change Models (LCMs).
This study looked at how pyridoxine, also known as vitamin B6, might help reduce neuropsychiatric side effects caused by the epilepsy medication levetiracetam in children and adolescents.
This study looked at how effective and safe the medication lacosamide (LCM) is for children and teenagers with drug-resistant epilepsy (DRE), which means their seizures do not respond well to standard treatments.
This study looked at how well the Modified Mini-Mental State Examination for Children (MMSEc) can identify intellectual disabilities in children aged 6 to 14.
Researchers studied the neurological effects of familial Mediterranean fever (FMF) in children under 18 years old.
This study looked at how epilepsy affects the oral and dental health of children.
A study was conducted to evaluate the effectiveness and safety of a medication called cenobamate (CNB) in treating patients with Lennox-Gastaut Syndrome (LGS), a severe form of epilepsy that often starts in childhood.
A recent study surveyed international experts to understand their recommendations for folic acid supplementation in pregnant people with epilepsy.
This study looked at how children aged 8 to 17 experience long-term video-electroencephalography monitoring (LTVEM), a procedure used to diagnose epilepsy when medications donβt work.